B-Cell Prolymphocytic Leukemia — Trials

B-Cell Prolymphocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02892695	PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma	unknown	Phase 1 / Phase 2	10	PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY	1	Dec 6, 2016	clinicaltrials
NCT02819583	CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma	unknown	Phase 1 / Phase 2	10	PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY	1	Oct 25, 2016